MAPK1 and Cognitive impairment: These results demonstrated that inhibition of the p38 or ERK2 signaling pathway alleviated cerebral infarction and neuron damage, cognitive impairment, and improved learning and memory abilities, as well as reduced the score of neurological function injury in MCAO mice.